» Articles » PMID: 16304072

Risk of Pelvic Fractures in Older Women Following Pelvic Irradiation

Overview
Journal JAMA
Specialty General Medicine
Date 2005 Nov 24
PMID 16304072
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Pelvic fractures, including hip fractures, are a major source of morbidity and mortality in older women. Although therapeutic pelvic irradiation could increase the risk of such fractures, this effect has not been studied.

Objective: To determine if women who undergo pelvic irradiation for pelvic malignancies (anal, cervical, or rectal cancers) have a higher rate of pelvic fracture than women with pelvic malignancies who do not undergo irradiation.

Design, Setting, And Participants: We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) cancer registry data linked to Medicare claims data. A total of 6428 women aged 65 years and older diagnosed with pelvic malignancies from 1986 through 1999 were included. We compared results for women who did (n = 2855) vs did not (n = 3573) undergo radiation therapy. To assess the influence of selection bias, we also evaluated the effect of irradiation on osteoporotic fractures in nonirradiated sites (arm and spine).

Main Outcome Measure: We evaluated the effect of irradiation on the incidence of pelvic fractures over time, and adjusted for potential confounders using a proportional hazards model.

Results: Women who underwent radiation therapy were more likely to have a pelvic fracture than women who did not undergo radiation therapy (cumulative 5-year fracture rate, 14.0% vs 7.5% in women with anal cancer, 8.2% vs 5.9% in women with cervical cancer, and 11.2% vs 8.7% in women with rectal cancer); the difference was statistically significant and most fractures (90%) were hip fractures. We controlled for potential confounders including age, race, cancer stage, and geographic location. The impact of irradiation varied by cancer site: treatment for anal cancer was associated with a higher risk of pelvic fractures (hazard ratio, 3.16; 95% confidence interval, 1.48-6.73); than for cervical cancer (hazard ratio, 1.66; 95% confidence interval, 1.06-2.59); or rectal cancer (hazard ratio, 1.65; 95% confidence interval, 1.33-2.05). No statistically significant difference was found in the rate of arm or spine fractures between the irradiated and nonirradiated groups (hazard ratio, 1.15; 95% confidence interval, 0.89-1.48).

Conclusions: Pelvic irradiation substantially increases the risk of pelvic fractures in older women. Given the high baseline risk of pelvic fracture, this finding is of particular concern.

Citing Articles

Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis.

Guo Y, Guo Z, Zhang J, Qian G, Ji W, Song L BMC Gastroenterol. 2025; 25(1):87.

PMID: 39962374 PMC: 11834637. DOI: 10.1186/s12876-025-03667-8.


Clinicopathologic features and exploration of new molecular mechanisms of radiation-induced bone injury: report of two cases and review of the literature.

Tao L, Bai C, Gao X, Zhang M, Qiu X, Yao Y Am J Cancer Res. 2025; 15(1):209-216.

PMID: 39949930 PMC: 11815379. DOI: 10.62347/OABR4439.


Suppressive effect of vitamin K (menatetrenone) against bone mineral density loss after radiotherapy in uterine cancer patients.

Kaneyasu Y, Fujiwara H, Akita T, Tanaka J, Shibata Y, Nakagawa T Jpn J Radiol. 2025; .

PMID: 39849242 DOI: 10.1007/s11604-025-01733-5.


Total body irradiation is associated with long-term deficits in femoral bone structure but not mechanical properties in male rhesus macaques.

Barnet I, Emerzian S, Behzad R, Brooks D, Tedtsen T, Granados M Sci Rep. 2024; 14(1):23379.

PMID: 39379502 PMC: 11461916. DOI: 10.1038/s41598-024-75363-8.


A Comprehensive Narrative Review of the Impact of Pelvic Radiotherapy on Pelvic Bone Health: Pathophysiology, Early Diagnosis, and Prevention Strategies.

Elgendy M, Billey A, Saleem A, Zeeshan B, Dissanayake G, Zergaw M Cureus. 2024; 16(8):e66839.

PMID: 39280418 PMC: 11398843. DOI: 10.7759/cureus.66839.